** Shares in IMCD IMCD.AS fall nearly 11%, to the bottom of Europe's STOXX 600 .STOXX index, after the Dutch chemicals and foods ingredients published Q4 results below expectations
** Quarterly EBITA came in 8% below consensus at 103.9 million euros ($122.99 million), while revenue declined 2.8% yoy when analysts expected a 1.4% growth, according to Jefferies
** The broker deems the update disappointing "with no evidence of a turnaround"
** Degroof Petercam notes a "still challenging environment", adds that the outlook statement does not indicate an imminent improvement
** IMCD did not provide guidance for 2026
** Shares are on track for their worst day since July 2025
($1 = 0.8448 euros)
(Reporting by Olivier Cherfan)
((olivier.cherfan@thomsonreuters.com))